Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial.

Abstract

Posttraumatic stress disorder (PTSD) is the most highly prevalent mental health disorder among U.S. military Veterans. Prolonged Exposure (PE) therapy is one of the most widely used evidence-based treatments for PTSD, but there is substantial room for improvement in outcomes and retention rates. Accumulating data suggest that oxytocin offers a promising pharmacological approach towards achieving this goal. Therefore, the primary objective of this two-site Phase II study is to examine the ability of oxytocin (vs. placebo) administration combined with PE therapy to (1) reduce PTSD symptom severity, (2) accelerate the rate of PTSD symptom improvement, and (3) improve PE adherence and retention rates. To accomplish these objectives, we will employ a randomized, double-blind, placebo-controlled trial and use standardized, repeated dependent measures of change at five time points (baseline, mid-treatment, end of treatment, and 3 and 6 month follow-up). Intranasal oxytocin (40 IU) will be administered directly prior to each PE therapy session. Findings from this study will provide critical new information regarding the efficacy of oxytocin to augment psychosocial treatment for PTSD, as well as information regarding the physiological mechanisms underlying PTSD and positive treatment response. ClinicalTrials.gov Identifier: NCT04228289.

• Authors: Julianne C Flanagan, Jennifer M Mitchell, Nathaniel L Baker, Joshua Woolley, Bethany Wangelin, Sudie E Back, John R McQuaid, Thomas C Neylan, William R Wolfe, Kathleen T Brady
• Journal: Contemporary clinical trials (Contemp Clin Trials) Vol. 95 Pg. 106074 (08 2020) ISSN: 1559-2030 [Electronic] United States
• PMID: 32561468 (Publication Type: Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
• Copyright: Copyright © 2020 Elsevier Inc. All rights reserved.

Chemical References

• Oxytocin

Topics

• Humans
• Implosive Therapy
• Oxytocin
• Stress Disorders, Post-Traumatic (drug therapy)
• Treatment Outcome
• Veterans